UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia

Biological psychiatry (1969), 2017-01, Vol.81 (1), p.67-77

2017

Link zum Volltext

Verfügbarkeit prüfen

Resting-state global brain activity affects early β-amyloid accumulation in default mode network

Nature communications, 2023-11, Vol.14 (1), p.7788-7788, Article 7788

2023

Link zum Volltext

Verfügbarkeit prüfen

Quantitative susceptibility mapping of the midbrain in Parkinson's disease

Movement disorders, 2016-03, Vol.31 (3), p.317-324

2016

Link zum Volltext

Verfügbarkeit prüfen

Functional selectivity and classical concepts of quantitative pharmacology

The Journal of pharmacology and experimental therapeutics, 2007-01, Vol.320 (1), p.1

2007

Link zum Volltext

Verfügbarkeit prüfen

Dopamine receptor signaling and current and future antipsychotic drugs

Handbook of experimental pharmacology, 2012-01 (212), p.53

2012

Link zum Volltext

Verfügbarkeit prüfen

Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder

Neuropsychopharmacology (New York, N.Y.), 2015-01, Vol.40 (2), p.446-453

2015

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional Repression by the BRG1-SWI/SNF Complex Affects the Pluripotency of Human Embryonic Stem Cells

Stem cell reports, 2014-09, Vol.3 (3), p.460-474

2014

Link zum Volltext

Verfügbarkeit prüfen

Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways

Neuropsychopharmacology (New York, N.Y.), 2007-01, Vol.32 (1), p.67-77

2007

Link zum Volltext

Verfügbarkeit prüfen

Dose-Dependent Regulation on Prefrontal Neuronal Working Memory by Dopamine D1 Agonists: Evidence of Receptor Functional Selectivity-Related Mechanisms

Frontiers in neuroscience, 2022-06, Vol.16, p.898051-898051

2022

Link zum Volltext

Verfügbarkeit prüfen

The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions

Journal of neurology, 2016-01, Vol.263 (1), p.68-75

2016

Link zum Volltext

Verfügbarkeit prüfen

Low plasma serotonin linked to higher nigral iron in Parkinson's disease

Scientific reports, 2021-12, Vol.11 (1), p.24384-12, Article 24384

2021

Link zum Volltext

Verfügbarkeit prüfen

Projection of the prevalence of Parkinson's disease in the coming decades: Revisited

Movement disorders, 2018-01, Vol.33 (1), p.156-159

2018

Link zum Volltext

Verfügbarkeit prüfen

Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Current pharmaceutical design, 2010-02, Vol.16 (5), p.488

2010

Link zum Volltext

Verfügbarkeit prüfen

Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study

Movement disorders, 2008-05, Vol.23 (7), p.1013-1018

2008

Link zum Volltext

Verfügbarkeit prüfen

GPCR functional selectivity has therapeutic impact

Trends in pharmacological sciences (Regular ed.), 2007-08, Vol.28 (8), p.390-396

Mailman, Richard B

2007

Link zum Volltext

Verfügbarkeit prüfen

Strategic neuronal encoding in medial prefrontal cortex of spatial working memory in the T-maze

Behavioural brain research, 2018-05, Vol.343, p.50-60

2018

Link zum Volltext

Verfügbarkeit prüfen

D1, not D2, dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa

European journal of pharmacology, 2021-02, Vol.892, p.173760-173760, Article 173760

2021

Link zum Volltext

Verfügbarkeit prüfen

D 1 , not D 2 , dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa

European journal of pharmacology, 2021-02, Vol.892, p.173760

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk

Frontiers in neurology, 2017-09, Vol.8, p.501-501

2017

Link zum Volltext

Verfügbarkeit prüfen

Cancer and the Dopamine D 2 Receptor: A Pharmacological Perspective

The Journal of pharmacology and experimental therapeutics, 2019-07, Vol.370 (1), p.111

2019

Link zum Volltext

Verfügbarkeit prüfen

Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease

Biomolecules (Basel, Switzerland), 2023-05, Vol.13 (5), p.829

2023

Link zum Volltext

Verfügbarkeit prüfen

A Dopamine D 1 Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory

The Journal of pharmacology and experimental therapeutics, 2022-08, Vol.382 (2), p.88

2022

Link zum Volltext

Verfügbarkeit prüfen

Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients

Movement disorders, 2018-09, Vol.33 (9), p.1423-1431

2018

Link zum Volltext

Verfügbarkeit prüfen

A novel role of CDX1 in embryonic epicardial development

PloS one, 2014-07, Vol.9 (7), p.e103271-e103271

2014

Link zum Volltext

Verfügbarkeit prüfen

Characterization of behavioral changes in T-maze alternation from dopamine D1 agonists with different receptor coupling mechanisms

Psychopharmacology, 2023-10, Vol.240 (10), p.2187-2199

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 265

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(246)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(132)
Life Sciences & Biomedicine
(122)
Animals
(107)
Male
(87)
Humans
(80)
Rats
(76)
Neurosciences & Neurology
(66)
Biological And Medical Sciences
(62)
Neurosciences
(53)
Pharmacology & Pharmacy
(51)
Medical Sciences
(49)
Female
(37)
Dopamine
(36)
Pharmacology. Drug Treatments
(34)
Middle Aged
(32)
Neuropharmacology
(31)
Parkinson's Disease
(29)
Dopamine - Metabolism
(26)
Psychiatry
(25)
Neurotransmitters. Neurotransmission. Receptors
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia

Resting-state global brain activity affects early β-amyloid accumulation in default mode network

Quantitative susceptibility mapping of the midbrain in Parkinson's disease

Functional selectivity and classical concepts of quantitative pharmacology

Dopamine receptor signaling and current and future antipsychotic drugs

Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder

Transcriptional Repression by the BRG1-SWI/SNF Complex Affects the Pluripotency of Human Embryonic Stem Cells

Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways

Dose-Dependent Regulation on Prefrontal Neuronal Working Memory by Dopamine D1 Agonists: Evidence of Receptor Functional Selectivity-Related Mechanisms

The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical regions

Low plasma serotonin linked to higher nigral iron in Parkinson's disease

Projection of the prevalence of Parkinson's disease in the coming decades: Revisited

Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study

GPCR functional selectivity has therapeutic impact

Strategic neuronal encoding in medial prefrontal cortex of spatial working memory in the T-maze

D1, not D2, dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa

D 1 , not D 2 , dopamine receptor activation dramatically improves MPTP-induced parkinsonism unresponsive to levodopa

Circulating Cholesterol Levels May Link to the Factors Influencing Parkinson's Risk

Cancer and the Dopamine D 2 Receptor: A Pharmacological Perspective

Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease

A Dopamine D 1 Agonist Versus Methylphenidate in Modulating Prefrontal Cortical Working Memory

Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients

A novel role of CDX1 in embryonic epicardial development

Characterization of behavioral changes in T-maze alternation from dopamine D1 agonists with different receptor coupling mechanisms

Suchergebnisse filtern